POTED - POTE ankyrin domain family member D Gene

Homo sapiens

Also known as POTE; A26B3; POTE21; ANKRD21; CT104.1; POTE-21

Gene ID: 317754 | Gene type: protein coding

About POTED

Cytogenetic location: 21q11.2 Genomic coordinates (GRCh38): 21:13,609,777-13,645,823 (from NCBI)

This gene has 2 transcripts (splice variants), 13 orthologues and 16 paralogues. Restricted expression toward testis (RPKM 4.0).

Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

mRNA	Protein	Name
NM_174981.6	NP_778146.2	POTE ankyrin domain family member D

Ank_2

Ank

Ank_2

CCDC144C

Protein Preferred Names

Protein Names

POTE ankyrin domain family member D

ANKRD26-like family B member 3

Diseases

Alias

Luminal Breast Carcinoma B

Luminal B Breast Carcinoma

Prostate Cancer

Prostate Carcinoma	Prostate Cancer, Familial
Prostate Neoplasm	Prostate Cancer, Somatic
Prostate Cancer, Susceptibility To	Prostatic Cancer
Prostatic Neoplasms	Hereditary Prostate Cancer
Prostatic Neoplasm	Cancer Of Prostate
Carcinoma Of Prostate	Familial Prostate Cancer
Familial Prostate Carcinoma	Malignant Tumor Of Prostate
Malignant Neoplasm Of Prostate	Prostate Cancer, Familial, Susceptibility To
Malignant Tumor Of The Prostate	Ngp - New Growth Of Prostate
Tumor Of The Prostate	Prostate Cancer, Hereditary
Cancer Of The Prostate	Malignant Neoplasm Of The Prostate
Prostatic Carcinoma	PC
Prca	Cancer, Prostate
Malignant Prostatic Tumour	Malignant Tumour Of Prostate
Primary Prostate Cancer	Primary Malignant Neoplasm Of Prostate
Prostate Gland Cancer

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Clinical Phase

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P3204	POT-4	Inhibitor	99.60%	Phase 2
HY-P3204A	POT-4 TFA	Inhibitor	/	Phase 2

Pre-clinical Phase

Bioactive Molecules (4)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B2046	Simazine		99.72%	Unkown
HY-B2046S	Simazine-d10		/	Unkown
HY-RS10885	POT1 Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-RS10889	POTED Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown

Species	Symbol	Source	ID
Rattus norvegicus	POTED	RGD	RGD:9472036

Name
Email *

	Sorry, but the email address you supplied was invalid.